Search Results - "Dahler, Ellen C."

QR‐421a RNA therapy in retinitis pigmentosa due to mutations in USH2A: Stellar trial Phase[AP1] 1b/2 interim results by Audo, Isabelle, Birch, David G., Thiran Jayasundera, K., Meunier, Isabelle, Huckfeldt, Rachel M., Koenekoop, Robert K., Yang, Paul, Cock, Edouard P. M., Dahler, Ellen C., Taylor, John, Shams, Naveed, Girach, Aniz

“…Purpose To report Phase 1b/2 interim results of QR‐421a RNA therapy promoting USH2A exon 13 skipping. USH2A exon 13 mutations lead to non‐syndromic Retinitis…”
Get full text

Roles of Radiation Dose, Chemotherapy, and Hormonal Factors in Breast Cancer Following Hodgkin’s Disease by van Leeuwen, Flora E., Klokman, Willem J., Stovall, Marilyn, Dahler, Ellen C., van’t Veer, Mars B., Noordijk, Evert M., Crommelin, Mariad A., Aleman, Berthe M. P., Broeks, Annegien, Gospodarowicz, Mary, Travis, Lois B., Russell, Nicola S.

“…Background: Female survivors of Hodgkin’s disease (HD) have a strongly elevated risk of breast cancer, but factors responsible for the increased risk are not…”
Get full text

ATM-Heterozygous Germline Mutations Contribute to Breast Cancer–Susceptibility by Broeks, Annegien, Urbanus, Jos H.M., Floore, Arno N., Dahler, Ellen C., Klijn, Jan G.M., Rutgers, Emiel J. Th, Devilee, Peter, Russell, Nicola S., van Leeuwen, Flora E., van't Veer, Laura J.

“…Approximately 0.5%–1% of the general population has been estimated to be heterozygous for a germline mutation in the ATM gene. Mutations in the ATM gene are…”
Get full text